Intravenous patient-controlled analgesia using remifentanil in a child with Axenfeld-Rieger syndrome

Area of Science:

• Anesthesiology
• Pediatric Surgery
• Pain Management

Background:

• Patient-controlled analgesia (PCA) with intravenous opioids is gaining traction for pediatric pain management in children aged 5 and older.
• Limited data exists on the use of remifentanil for PCA in the pediatric postoperative setting.

Observation:

• A case report details the successful administration of intravenous remifentanil PCA to a pediatric patient.
• The patient underwent a suprasellar arachnoid cystectomy and presented with Axenfeld-Rieger syndrome, requiring robust pain management due to associated complications.

Findings:

• Remifentanil administered via intravenous patient-controlled analgesia (PCA) provided effective postoperative pain control in this pediatric case.
• The successful use highlights the feasibility of remifentanil PCA in children with complex medical histories and significant pain requirements.

Implications:

• This case suggests that remifentanil IV PCA is a viable option for managing severe postoperative pain in select pediatric patients.
• Further research into remifentanil PCA in children could expand its application in pediatric anesthesia and critical care.